Dianthus Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-29.1M | $-29.4M | $314.0K | $1.5M |
| FY2023 | $-36.9M | $-36.9M | — | $2.9M |
| FY2024 | $-78.2M | $-78.2M | — | $12.9M |
| FY2025 | $-129.1M | $-129.1M | — | $22.8M |